https://www.selleckchem.com/pr....oducts/zotatifin.htm
The median time to recurrence with Interquartile Range (IQR) was 13 months IQR [8-30]. The overall respective 3-years OS and RFS were 78.5% (IC95% 74.5-82.5) and 75.5% (IC95% 71.1-80.. According to FIGO stage, lymph node status and positive lympho-vascular invasion (LVSI), pattern and time of loco-regional and distant recurrence were significantly different. There wasn't interaction between FIGO stage and LVSI in OS neither RFS (p=0.08 and 0.9 respectively). Conclusion and discussion We report specific time and site patterns of firs